MedTrace Logo

Severe Cutaneous Adverse Reactions in Thailand

NCT02574988 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2019-02-18

No results posted yet for this study

Summary

The multicenter registry of patients with severe cutaneous adverse reactions among tertiary medical institutes in Thailand to study clinical characteristics, etiologies, therapeutic outcomes, quality of life, and the values of in vitro drug allergy diagnosis for the confirmation of the causative drugs

Conditions

  • Steven-Johnson Syndrome
  • Toxic Epidermal Necrolysis
  • Drug Reaction With Eosinophilia and Systemic Symptoms
  • Acute Generalized Exanthematous Pustulosis
  • Generalized Bullous Fixed Drug Eruption

Sponsors & Collaborators

  • Chiang Mai University

    collaborator OTHER

  • Thammasat University

    collaborator OTHER

  • Phramongkutklao College of Medicine and Hospital

    collaborator OTHER

  • Mahidol University

    collaborator OTHER

  • Chulalongkorn University

    lead OTHER

Principal Investigators

  • Jettanong Klaewsongkram, MD · Chulalongkorn University

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02574988 on ClinicalTrials.gov